I'm gonna say it before it's too late,
now it's Hematide that I hate.
Anemia is the illnes it works on.
But on the market it's not done.
It's in clinical research stage three,
It is an it and definitely not a he.
I have to write a protocol for it.
It has to be ready tomorrow. I'm deep in Sha-it
That's why I'll write in the report:
HEHAW.
And I'll pretend I am not a talking donkey,
but a dumb one